News

Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, And Forecast
Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...
The Manila Times5h
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration ...
Medical Dialogues2h
Sanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to age-related macular degeneration
Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...
TMCnet23h
AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...
Verywell Health on MSN20h
What Happens to Your Body When You Add Omega 3 Fatty Acids to Your Diet
Omega-3 fatty acids are a type of essential fats linked to many health benefits, such as heart health, reduced inflammation, ...
Cancer drug shows promise as treatment for blindness
Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...
BMJ7h
Impact of a community-based asynchronous review clinic on appointment attendance delays across an eye hospital network in London, UK: an interrupted time series analysis
Initially, services were for monitoring patients with stable glaucoma, age-related macular degeneration and diabetic retinopathy ... in the days just before or just after the LCAD to affect the mean ...